Andrade, Matheus de Oliveira, et al. “Immune-Related Adverse Events Among Patients With Early-Stage Triple-Negative Breast Cancer Treated With Pembrolizumab Plus Chemotherapy: Real-World Data from the Neo-Real GBECAM-0123 Study”. Mastology, vol. 35, no. suppl.1, Feb. 2026, doi:10.29289/259453942025V35S1030.